Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Elevation Oncology
Elevation Oncology
Hoffmann-La Roche
Boston Scientific Corporation
Pfizer
Imunon
NanOlogy, LLC
Theseus Pharmaceuticals
Kyowa Kirin Co., Ltd.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Hoffmann-La Roche
Celgene
Novartis
NanOlogy, LLC
Isofol Medical AB
Novartis
Exact Sciences Corporation
Novartis
Pfizer